Video modal
popup modal
The MHICC is now Seriant !
The Montreal Health Innovations Coordinating Center (MHICC) is now Seriant.
Our new name reflects a bold step forward— expanding beyond cardiology and embracing innovations in clinical trials with a global reach.
While our identity has evolved, our commitment to operational excellence, client satisfaction, and quality remains the same.
Daniel Houde, BSc, MBA, LLB
Head, Clinical Quality Assurance
With 40+ years of experience in quality assurance, Daniel Houde brings unparalleled expertise in delivering inspection-ready GCP compliance for pharma, biotech, medtech and CROs across North America, Europe, and Asia. He has prepared organizations for FDA, Health Canada, MHRA, ANSM, PMDA inspections and designed global GCP audit programs.
Daniel partners with sponsors to navigate complex protocols, vendor qualification, and risk-based quality systems—ensuring data integrity, participant safety, and operational efficiency from FIH through commercialization. His experience spans Abbott, Quintiles/IQVIA, Novartis, Alexion, Biorasi, and now Seriant, where he builds robust quality frameworks that de-risk clinical trials.
With deep expertise in Lean and Six Sigma methodologies, Daniel combines strategic oversight with hands-on coaching to deliver trials that withstand regulatory scrutiny.
